Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity

Previous report showed that a variety of icotinib derivatives bearing different 1,2,3-triazole moieties, which could be readily prepared via copper (I)-catalyzed cycloaddition (CuAAC) reaction between icotinib and different azides, exhibited interesting activity against different lung cancer cell li...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaojie, Mao, Long-Fei, Tian, Siqi, Tian, Xueli, Meng, Xueqiong, Wang, Mu-Kuo, Xu, Weifeng, Li, Yue-Ming, Liu, Kangdong, Dong, Zigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709406/
https://www.ncbi.nlm.nih.gov/pubmed/36467103
http://dx.doi.org/10.3389/fphar.2022.1028692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709406/
https://www.ncbi.nlm.nih.gov/pubmed/36467103
http://dx.doi.org/10.3389/fphar.2022.1028692

Ejemplares similares